Wayne Erwin, Chief Executive Officer of Oncologix Tech, Inc. (OTCPK:OCLG) stated, "We are pleased with the results of our second quarter fiscal 2015". Wayne Erwin further added, "We continue to execute our strategy to focuses on strategic acquisitions and debt reduction, both of which continue to increase Oncologix's market value."
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+164.00% | 6.65B | |
+2.00% | 981M | |
+0.19% | 928M | |
+41.91% | 872M | |
+14.60% | 804M | |
+1.91% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+29.64% | 552M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Seeks Acquisitions